Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech® Provides Updated Clinical Safety Data For Pelareorep, Including Across Multiple Gastrointestinal Tumors

Sept 2 (Reuters) - Oncolytics Biotech Inc ONYN.BE:

ONCOLYTICS BIOTECH® PROVIDES UPDATED CLINICAL SAFETY DATA FOR PELAREOREP, INCLUDING ACROSS MULTIPLE GASTROINTESTINAL TUMORS

ONCOLYTICS BIOTECH INC - FAVORABLE SAFETY PROFILE FOR PELAREOREP ACROSS MULTIPLE INDICATIONS

ONCOLYTICS BIOTECH INC - INTRAVENOUSLY ADMINISTERED PELAREOREP CONTINUES TO SHOWS CLINICAL BENEFIT

Source text: ID:nCNW4ld3Pa

Further company coverage: ONYN.BE

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news